Early Postoperative Intervention in Gastric Cancer Patients (NCT07444099) | Clinical Trial Compass
By InvitationNot Applicable
Early Postoperative Intervention in Gastric Cancer Patients
China264 participantsStarted 2026-02-10
Plain-language summary
This study was conducted by Qilu Hospital and five other renowned medical centers, aiming to evaluate the impact of early structured postoperative intervention on quality of life and prognosis in patients with gastric cancer after neoadjuvant therapy.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18-80 years;
* Histologically confirmed adenocarcinoma by preoperative pathology;
* Completed preoperative neoadjuvant therapy without obvious immune-related adverse events (irAEs);
* Patients with ycT3-4N+Mx disease deemed surgically resectable based on evaluation by gastroscopy, CT, PET-CT, and other imaging modalities;
* Signed informed consent and voluntary participation in this study;
* Standard ERAS (Enhanced Recovery After Surgery) management during the - perioperative period, with postoperative hospital stay ≤7 days.
Exclusion Criteria:
* Patients with central nervous system diseases or psychiatric disorders;
* Patients with severe diseases of other organ systems;
* Patients with recurrent infectious diseases or severe comorbidities;
* Patients requiring synchronous surgery for other diseases;
* Patients undergoing emergency surgery;
* Patients who developed any complication during hospitalization.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
incidence of complications within 30 days postoperatively
Timeframe: 30 days after operation
2
Postoperative recovery quality
Timeframe: Baseline (Day of Discharge) and POD 30（30 days after surgery）